Food Additives Linked to Inflammation

Commonly added to processed foods, emulsifiers are associated with changes in gut microbiome composition and increased inflammation in mice.

Written byJenny Rood
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, TRICIATwo of the 15 most common emulsifiers that bind the oily and watery components of processed foods can alter the gut microbiome and reduce the barrier layer of mucus between immune cells and bacteria, according to a mouse study published this week (February 25) in Nature. As a result, mice that consumed the emulsifiers were more prone to a range of symptoms that are hallmarks of inflammatory disease and metabolic syndrome, researchers reported.

Researchers at Georgia State University and Cornell provided inflammation-prone mice and wild-type controls with water containing the emulsifiers carboxymethylcellulose or polysorbate 80 for 12 weeks. At emulsifier levels ranging from 0.1 percent to 1 percent—the maximum recommended by the US Food and Drug Administration—the inflammation-prone mice saw doubled risk of developing colitis; both sets of mice ate more, gained 7 percent of their body weight, developed resistance to insulin, and had higher blood sugar levels, all of which are elements of metabolic syndrome.

In the emulsifier-fed mice, the scientists found that the average width of the protective layer of mucus in the gut that keeps the microbiome from coming in contact with immune cells and triggering inflammatory responses was reduced by half. At the same ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies